530 / | HD | CHEMISTRY: NATURAL RESINS OR DERIVATIVES; PEPTIDES OR PROTEINS; LIGNINS OR REACTION PRODUCTS THEREOF |
|
350 | DF | PROTEINS, I.E., MORE THAN 100 AMINO ACID RESIDUES {14} |
380 | DF | .~ Blood proteins or globulins, e.g., proteoglycans, platelet factor 4, thyroglobulin, thyroxine, etc. {3} |
386 | DF | .~.~ Globulins {4} |
387.1 | | .~.~.~ Immunoglobulin, antibody, or fragment thereof, other than immunoglobulin antibody, or fragment thereof that is conjugated or absorbed {9} |
387.2 | DF | .~.~.~.~> Anti-idiotypic |
387.3 | DF | .~.~.~.~> Chimeric, mutated, or recombined hybrid (e.g., bifunctional, bispecific, rodent-human chimeric, single chain, rFv, immunoglobulin fusion protein, etc.) |
387.5 | DF | .~.~.~.~> Binds oligosaccharide structure |
387.7 | DF | .~.~.~.~> Binds expression product of cancer-related gene or fragment thereof (e.g., oncogene, proto-oncogene, etc.) |
387.9 | DF | .~.~.~.~> Binds specifically-identified amino acid sequence |
388.1 | DF | .~.~.~.~> Monoclonal {3} |
389.1 | DF | .~.~.~.~> Polyclonal antibody or immunogloblin of identified binding specificity {7} |
390.1 | DF | .~.~.~.~> Removing or inactivating virus or bacterium or component or product thereof (e.g., endotoxin, etc.) |
390.5 | DF | .~.~.~.~> Removing, dissociating, or preventing the formation of aggregated, denatured, fragmented, or polymerized immunoglobulin or antibody; or preventing or reducing complement fixation or binding; or reducing antigenicity; or removing, inactivating, or inhibiting contaminating plasma proteins (e.g., proteolytic enzymes, etc.) |